BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 22249269)

  • 21. The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells.
    Li DD; Wang LL; Deng R; Tang J; Shen Y; Guo JF; Wang Y; Xia LP; Feng GK; Liu QQ; Huang WL; Zeng YX; Zhu XF
    Oncogene; 2009 Feb; 28(6):886-98. PubMed ID: 19060920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells.
    Bost F; McKay R; Bost M; Potapova O; Dean NM; Mercola D
    Mol Cell Biol; 1999 Mar; 19(3):1938-49. PubMed ID: 10022881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The small GTPase Rac1 is involved in the maintenance of stemness and malignancies in glioma stem-like cells.
    Yoon CH; Hyun KH; Kim RK; Lee H; Lim EJ; Chung HY; An S; Park MJ; Suh Y; Kim MJ; Lee SJ
    FEBS Lett; 2011 Jul; 585(14):2331-8. PubMed ID: 21704033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of lymphocyte-specific protein tyrosine kinase (LCK) in the expansion of glioma-initiating cells by fractionated radiation.
    Kim RK; Yoon CH; Hyun KH; Lee H; An S; Park MJ; Kim MJ; Lee SJ
    Biochem Biophys Res Commun; 2010 Nov; 402(4):631-6. PubMed ID: 20971076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fullerene derivative prevents cellular transformation induced by JAK2 V617F mutant through inhibiting c-Jun N-terminal kinase pathway.
    Funakoshi-Tago M; Nagata T; Tago K; Tsukada M; Tanaka K; Nakamura S; Mashino T; Kasahara T
    Cell Signal; 2012 Nov; 24(11):2024-34. PubMed ID: 22750290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Importance of PKCĪ“ signaling in fractionated-radiation-induced expansion of glioma-initiating cells and resistance to cancer treatment.
    Kim MJ; Kim RK; Yoon CH; An S; Hwang SG; Suh Y; Park MJ; Chung HY; Kim IG; Lee SJ
    J Cell Sci; 2011 Sep; 124(Pt 18):3084-94. PubMed ID: 21878493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of c-Jun N-terminal kinase sensitizes tumor cells to flavonoid-induced apoptosis through down-regulation of JunD.
    Kook SH; Son YO; Jang YS; Lee KY; Lee SA; Kim BS; Lee HJ; Lee JC
    Toxicol Appl Pharmacol; 2008 Mar; 227(3):468-76. PubMed ID: 18078968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
    Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
    J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bex2 regulates cell proliferation and apoptosis in malignant glioma cells via the c-Jun NH2-terminal kinase pathway.
    Zhou X; Meng Q; Xu X; Zhi T; Shi Q; Wang Y; Yu R
    Biochem Biophys Res Commun; 2012 Oct; 427(3):574-80. PubMed ID: 23022184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Phenotype of SHG-44 glioma stem cell spheres and pathological characteristics of their xenograft tumors].
    Wu TF; Chen JM; Chen SS; Chen GL; Wei YX; Xie XS; Du ZW; Zhou YX
    Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):726-31. PubMed ID: 24378091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel berbamine derivative inhibits cell viability and induces apoptosis in cancer stem-like cells of human glioblastoma, via up-regulation of miRNA-4284 and JNK/AP-1 signaling.
    Yang F; Nam S; Brown CE; Zhao R; Starr R; Ma Y; Xie J; Horne DA; Malkas LH; Jove R; Hickey RJ
    PLoS One; 2014; 9(4):e94443. PubMed ID: 24732116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sevoflurane modulates the cancer stem cell-like properties and mitochondrial membrane potential of glioma via Ca
    Han XC; Zhang YJ; Dong X; Xing QZ; Li KH; Zhang L
    Life Sci; 2020 Jul; 253():117675. PubMed ID: 32360621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells.
    Khatlani TS; Wislez M; Sun M; Srinivas H; Iwanaga K; Ma L; Hanna AE; Liu D; Girard L; Kim YH; Pollack JR; Minna JD; Wistuba II; Kurie JM
    Oncogene; 2007 Apr; 26(18):2658-66. PubMed ID: 17057737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition.
    Yoo YD; Lee DH; Cha-Molstad H; Kim H; Mun SR; Ji C; Park SH; Sung KS; Choi SA; Hwang J; Park DM; Kim SK; Park KJ; Kang SH; Oh SC; Ciechanover A; Lee YJ; Kim BY; Kwon YT
    EMBO Rep; 2017 Jan; 18(1):150-168. PubMed ID: 27993939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL33 Promotes Colon Cancer Cell Stemness via JNK Activation and Macrophage Recruitment.
    Fang M; Li Y; Huang K; Qi S; Zhang J; Zgodzinski W; Majewski M; Wallner G; Gozdz S; Macek P; Kowalik A; Pasiarski M; Grywalska E; Vatan L; Nagarsheth N; Li W; Zhao L; Kryczek I; Wang G; Wang Z; Zou W; Wang L
    Cancer Res; 2017 May; 77(10):2735-2745. PubMed ID: 28249897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. JNK signaling mediates EPHA2-dependent tumor cell proliferation, motility, and cancer stem cell-like properties in non-small cell lung cancer.
    Song W; Ma Y; Wang J; Brantley-Sieders D; Chen J
    Cancer Res; 2014 May; 74(9):2444-54. PubMed ID: 24607842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells.
    Wang CC; Chiang YM; Sung SC; Hsu YL; Chang JK; Kuo PL
    Cancer Lett; 2008 Jan; 259(1):82-98. PubMed ID: 18023967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crosstalk between the PI3K/mTOR and MEK/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells.
    Sunayama J; Matsuda K; Sato A; Tachibana K; Suzuki K; Narita Y; Shibui S; Sakurada K; Kayama T; Tomiyama A; Kitanaka C
    Stem Cells; 2010 Nov; 28(11):1930-9. PubMed ID: 20857497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conflicting evidence for the role of JNK as a target in breast cancer cell proliferation: Comparisons between pharmacological inhibition and selective shRNA knockdown approaches.
    Wood RA; Barbour MJ; Gould GW; Cunningham MR; Plevin RJ
    Pharmacol Res Perspect; 2018 Feb; 6(1):. PubMed ID: 29417765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-Jun N-terminal kinase (JNK) regulation of iNOS expression in glial cells: predominant role of JNK1 isoform.
    Pawate S; Bhat NR
    Antioxid Redox Signal; 2006; 8(5-6):903-9. PubMed ID: 16771680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.